SoftOx Solutions AS is pleased to invite investors, analysts and other
stakeholders to our extended 2Q 2022 results presentation on Monday August 15th,
2022. The event will be held in-person as well as being streamed live. The
interim report and related materials will be made available on
https://soft-ox.com/financial-calendar-reports/.

The 2Q 2022 results will be released at 07:00 (CET) on Monday August 15th, 2022
and will be presented by the management at 10:00 (CET) at SpareBank 1 Markets,
Olav V's gate 5, Norway. The presentation is open to the public and can also be
followed via the link:
https://channel.royalcast.com/landingpage/hegnarmedia/20220815_2/

The presentation will be held in English and followed by a Q&A session.
Please register for the event before August 15th, at 08:00 (CET). 

For any questions or interview requests, please contact:
Geir Almås, CEO of SoftOx Solutions AS, or
Kristine Rød, CFO at SoftOx Solutions AS
Mail: ir@soft-ox.com
Phone: Front Desk: (+47) 948-59-599

About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
medtech/biotech company based in Oslo with the aim of helping to combat major
threats to human health, namely the emergence of antimicrobial resistance (AMR),
biofilm infections in chronic wounds and the spread of viruses. For more
information on SoftOx, visit www.soft-ox.com